Influenza A Clinical Charting
Document influenza A with specific vital signs, symptom onset timing, risk stratification, and treatment decisions including antiviral eligibility and antibiotic indications based on severity and complications.
Essential Documentation Elements
Initial Assessment Parameters
Chart the following vital signs at least twice daily (more frequently if severe) 1:
- Temperature (fever defined as >38°C in adults, >38.5°C in children)
- Respiratory rate (≥30/min indicates severity)
- Heart rate (>100/min suggests instability)
- Blood pressure (SBP <90 or DBP ≤60 mmHg indicates severity)
- Oxygen saturation (target >92%, or pO2 >8 kPa)
- Mental status (confusion scores 1 point on CURB-65)
- Inspired oxygen concentration (FiO2)
Critical Timing Documentation
Document symptom onset time precisely - this determines antiviral eligibility. Treatment with oseltamivir is only indicated if the patient presents within 48 hours of symptom onset 1, 2.
Risk Stratification Documentation
Chart whether the patient has high-risk features 1:
- Chronic respiratory disease (asthma on inhaled steroids, COPD, cystic fibrosis)
- Chronic heart disease (heart failure, ischemic heart disease requiring medication)
- Chronic renal disease (nephrotic syndrome, renal failure, transplant)
- Chronic liver disease (cirrhosis, inflammatory bowel disease)
- Diabetes requiring insulin or oral hypoglycemics
- Immunosuppression (HIV, malignancy, chemotherapy, steroids >20mg prednisolone daily for >1 month)
- Pregnancy
- Age ≥65 years
- Long-term care facility resident
Severity Assessment and Documentation
CURB-65 Score Calculation
Document each component 1:
- Confusion (present/absent)
- Urea >7 mmol/L
- Respiratory rate ≥30/min
- Blood pressure (SBP <90 or DBP ≤60)
- Age ≥65 years
Score interpretation:
- 0-2: Non-severe pneumonia
- 3-5: Severe pneumonia requiring aggressive management
Pneumonia Classification
Document whether pneumonia is present and its pattern:
- No pneumonia: Uncomplicated influenza or bronchitis
- Non-severe pneumonia: CURB-65 score 0-2
- Severe pneumonia: CURB-65 score 3-5 OR bilateral chest radiograph changes (primary viral pneumonia)
Treatment Documentation
Antiviral Therapy
Document oseltamivir administration if ALL criteria met 1, 2:
- Acute influenza-like illness present
- Fever >38°C (adults) or >38.5°C (children)
- Symptomatic for ≤48 hours
Dosing to chart:
- Adults: 75 mg every 12 hours for 5 days
- Reduce to 75 mg once daily if creatinine clearance <30 mL/min
- Children dosing by weight 1:
- <15 kg: 30 mg every 12 hours
- 15-23 kg: 45 mg every 12 hours
- ≥24 kg: 75 mg every 12 hours
Exceptions to document (may treat despite lack of fever or >48 hours) 1:
- Immunocompromised patients
- Very elderly unable to mount febrile response
- Severely ill hospitalized patients
- Severely ill children <1 year (note: off-label use)
Antibiotic Therapy Documentation
Chart antibiotic decisions algorithmically 1:
No Pneumonia Present:
- Previously well patients: No antibiotics routinely 1, 2
- Worsening symptoms (recrudescent fever, increasing dyspnea): Consider antibiotics
- High-risk patients with lower respiratory features: Strongly consider antibiotics
Non-Severe Pneumonia (CURB-65 0-2):
- First-line oral: Co-amoxiclav OR tetracycline (doxycycline)
- Penicillin allergy: Clarithromycin or fluoroquinolone (levofloxacin/moxifloxacin)
- Administer within 4 hours of admission 1
Severe Pneumonia (CURB-65 3-5 or bilateral infiltrates):
- Immediate IV combination: Co-amoxiclav (or cefuroxime/cefotaxime) PLUS clarithromycin/erythromycin
- Alternative: Fluoroquinolone with anti-pneumococcal and anti-staphylococcal activity
Supportive Care Documentation
Chart the following interventions 1:
- Oxygen therapy: Maintain pO2 >8 kPa or SaO2 >92%
- IV fluids: Document volume status assessment and replacement
- Nutritional support: In severe or prolonged illness
- Cardiac assessment: Screen for complications
- Non-invasive ventilation: Consider in respiratory failure when ICU beds limited (requires experienced unit)
Discharge Criteria Documentation
Review 24 hours before discharge - patient should have <2 of these unstable factors 1, 2:
- Temperature >37.8°C
- Heart rate >100/min
- Respiratory rate >24/min
- Systolic BP <90 mmHg
- Oxygen saturation <90%
- Inability to maintain oral intake
- Abnormal mental status
Follow-Up Documentation
Chart discharge plan including 1:
- Follow-up arrangements with GP or hospital clinic for patients with significant complications or worsening comorbidities
- Patient education about illness, medications, and follow-up
- Communication with GP regarding hospital course and ongoing management needs
Pediatric-Specific Documentation
For children, additionally document 1:
Indicators for HDU/ICU transfer:
- SaO2 <92% despite FiO2 >0.6
- Shock
- PaCO2 >6.5 kPa with severe respiratory distress
- Rising respiratory/pulse rate with severe distress
- Recurrent apnea or irregular breathing
- Encephalopathy
Antibiotic dosing by age (if indicated) 1:
- Co-amoxiclav: 1-12 months (2.5 mL/kg of 125/31 suspension TDS), 1-6 years (5 mL TDS), 7-12 years (5 mL of 250/62 TDS)
- Clarithromycin: Weight-based from 7.5 mg/kg BD to 250 mg BD
Common Pitfalls to Avoid
- Do not delay antiviral treatment waiting for test results if patient presents within 48 hours with typical features
- Do not give antibiotics routinely to previously well patients without pneumonia
- Do not discharge patients with ≥2 unstable vital sign criteria
- Do not forget renal dose adjustment for oseltamivir (50% reduction if CrCl <30)
- Do not overlook high-risk patients who may benefit from antibiotics even without confirmed pneumonia